TY - JOUR
T1 - Human vitreous levels of selected antistaphylococcal antibiotics
AU - Axelrod, Judith L.
AU - Klein, Richard M.
AU - Bergen, Robert L.
AU - Sheikh, Mohamed Z.
PY - 1985/10
Y1 - 1985/10
N2 - Staphylococcus epidermidis and S. aureus are the most common causes of bacterial endophthalmitis. A study of the penetration of selected antistaphylococcal antibiotics into human vitreous was undertaken in 58 patients. After 2-g intravenous doses of cephalothin, cefazolin, methicillin, oxacillin, or nafcillin were given to patients about to undergo vitreous surgery, mean vitreous levels for each antibiotic were as follows: cephalothin, 0.97 μg/ml in diabetics and 0.69 μg/ml in nondiabetics; cefazolin, 0.84 μg/ml in diabetics and 1.6 μg/ml in nondiabetics; methicillin, 2.56 μg/ml in diabetics and 2.64 μg/ml in nondiabetics; oxacillin, 0.62 μg/ml in diabetics and 0.34 μg/ml in nondiabetics; and nafcillin, 0.73 μg/ml in diabetics and 0.75 μg/ml in nondiabetics. Only cefazolin produced vitreous concentrations consistently above its minimum inhibitory concentration for 90% of S. epidermidis isolates. Staphylococcus aureus isolates were not similarly covered. There was a trend toward higher vitreous antibiotic concentrations in patients with proliferative vitre-oretinopathy and rubeosis.
AB - Staphylococcus epidermidis and S. aureus are the most common causes of bacterial endophthalmitis. A study of the penetration of selected antistaphylococcal antibiotics into human vitreous was undertaken in 58 patients. After 2-g intravenous doses of cephalothin, cefazolin, methicillin, oxacillin, or nafcillin were given to patients about to undergo vitreous surgery, mean vitreous levels for each antibiotic were as follows: cephalothin, 0.97 μg/ml in diabetics and 0.69 μg/ml in nondiabetics; cefazolin, 0.84 μg/ml in diabetics and 1.6 μg/ml in nondiabetics; methicillin, 2.56 μg/ml in diabetics and 2.64 μg/ml in nondiabetics; oxacillin, 0.62 μg/ml in diabetics and 0.34 μg/ml in nondiabetics; and nafcillin, 0.73 μg/ml in diabetics and 0.75 μg/ml in nondiabetics. Only cefazolin produced vitreous concentrations consistently above its minimum inhibitory concentration for 90% of S. epidermidis isolates. Staphylococcus aureus isolates were not similarly covered. There was a trend toward higher vitreous antibiotic concentrations in patients with proliferative vitre-oretinopathy and rubeosis.
UR - http://www.scopus.com/inward/record.url?scp=0022386693&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022386693&partnerID=8YFLogxK
U2 - 10.1016/0002-9394(85)90683-X
DO - 10.1016/0002-9394(85)90683-X
M3 - Article
C2 - 3876773
AN - SCOPUS:0022386693
SN - 0002-9394
VL - 100
SP - 570
EP - 575
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
IS - 4
ER -